Unijules Life Sciences Ltd. is a diversified group of companies specializing in pharmaceuticals, injectables, herbals, and nutraceuticals. With a remarkable 85-year legacy, the company has positioned itself as a global healthcare leader, exporting products to over 40 countries in Asia and Europe. Their state-of-the-art facilities are certified by WHO-GMP, GMP, ISO 22000-2018, and ISO 9001–2015, ensuring superior quality. Unijules excels in innovative technologies such as Contrast Media, Pellets Technology, Direct Compressible Granules, Premix, Taste Masking, and Specialized Cream/Gel. Furthermore, they offer contract and third-party manufacturing to meet diverse healthcare needs globally.
Since their establishment in 2004, Unijules Life Sciences Ltd. operates in the Health Care, Manufacturing, and Pharmaceutical industries, showcasing a commitment to innovation and excellence in healthcare. Although specific headquarters and recent investment details are not disclosed, their extensive experience and global reach make Unijules an intriguing prospect for potential investors in the healthcare and pharmaceutical sectors.
There is no investment information
No recent news or press coverage available for Unijules Life Sciences Ltd..
We care about your data, and we'd love to use cookies make your experience better.
